Precision BioSciences' gene editing therapy PBGENE-HBV eliminated hepatitis B's cccDNA viral reservoir in every evaluable ...

A retrospective cohort study evaluated baseline clinical, virological, and fibrosis-related predictors of direct-acting antiviral failure in adults with concurrent hepatitis B and hepatitis C ...

Hepatitis B is a viral infection that impacts the liver. To test for hepatitis B, a doctor can perform a blood test that detects hepatitis B surface antigens. A positive result indicates a hepatitis B ...

Hepatitis B testing can show whether you have a current or past HBV infection and whether you have antibodies from a hepatitis B vaccine. Hepatitis B is a viral infection caused by the hepatitis B ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing therapies for high unmet need ...

Vaccination against hepatitis B is a common recommendation, but what exactly is it preventing? HHS Secretary Robert F. Kennedy Jr. and his advisory group plan to meet this week to discuss and vote on ...

Hepatitis B and herpes simplex virus are both sexually transmitted infections (STIs). However, they are not the same and develop due to different viruses. STIs spread from one person to another ...

Hepatitis B virus (HBV) has a narrow host range, mainly infecting hominoids. A new study reveals the structural differences in the liver cell receptor (NTCP) between humans and monkeys, explaining why ...

SAN FRANCISCO, April 22, 2024 (GLOBE NEWSWIRE) -- Excision BioTherapeutics, Inc. ("Excision", the "Company"), a clinical-stage biotechnology company developing CRISPR-based therapies to cure serious ...

A community-based survey in Tolon, Ghana, revealed a 7.2 percent hepatitis B seroprevalence among adults, with significantly ...